Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Matt O'Brien's Stock Ratings
Piper Sandler Analyst
Matt O'Brien is an analyst at Piper Sandler. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 05/02/2025
Overall Average Return
-6.95%
Smart Score
Overall Average Return Percentile
26th
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 05/02/2025 | DXCM | Buy Now | DexCom | $81.28 | 10.73% | Matt O'Brien51% | $100 → $90 | Maintains | Overweight | Get Alert |
| 05/02/2025 | ATEC | Buy Now | Alphatec Holdings | $12.00 | 25% | Matt O'Brien51% | $13 → $15 | Reiterates | Overweight → Overweight | Get Alert |
| 05/01/2025 | TNDM | Buy Now | Tandem Diabetes Care | $21.30 | 40.85% | Matt O'Brien51% | $36 → $30 | Maintains | Overweight | Get Alert |
| 04/29/2025 | TMDX | Buy Now | TransMedics Group | $90.50 | 16.02% | Matt O'Brien51% | $90 → $105 | Reiterates | Overweight → Overweight | Get Alert |
| 04/15/2025 | GKOS | Buy Now | Glaukos | $87.61 | 88.33% | Matt O'Brien51% | $180 → $165 | Maintains | Overweight | Get Alert |
| 03/31/2025 | KMTS | Buy Now | Kestra Medical Techs | $23.75 | 13.68% | Matt O'Brien51% | → $27 | Initiates | → Overweight | Get Alert |
| 03/21/2025 | TELA | Buy Now | TELA Bio | $1.00 | 99.88% | Matt O'Brien51% | $5 → $2 | Downgrade | Overweight → Neutral | Get Alert |
| 03/06/2025 | SGHT | Buy Now | Sight Sciences | $3.05 | 14.75% | Matt O'Brien51% | $5.5 → $3.5 | Maintains | Neutral | Get Alert |
| 02/28/2025 | TFX | Buy Now | Teleflex | $126.41 | 10.75% | Matt O'Brien51% | $255 → $140 | Downgrade | Overweight → Neutral | Get Alert |
| 02/27/2025 | ATEC | Buy Now | Alphatec Holdings | $12.00 | 8.33% | Matt O'Brien51% | $12 → $13 | Maintains | Overweight | Get Alert |
| 02/24/2025 | BBNX | Buy Now | Beta Bionics | $11.83 | 119.78% | Matt O'Brien51% | → $26 | Initiates | → Overweight | Get Alert |
| 02/21/2025 | PODD | Buy Now | Insulet | $257.01 | 20.62% | Matt O'Brien51% | $285 → $310 | Maintains | Overweight | Get Alert |
| 02/19/2025 | PEN | Buy Now | Penumbra | $296.00 | 11.49% | Matt O'Brien51% | $250 → $330 | Reiterates | Overweight → Overweight | Get Alert |
| 02/13/2025 | ATRC | Buy Now | AtriCure | $30.02 | 66.56% | Matt O'Brien51% | $40 → $50 | Maintains | Overweight | Get Alert |
| 02/12/2025 | STAA | Buy Now | Staar Surgical | $19.03 | -15.92% | Matt O'Brien51% | $40 → $16 | Maintains | Neutral | Get Alert |
| 02/05/2025 | CVRX | Buy Now | CVRx | $7.95 | 151.57% | Matt O'Brien51% | $16 → $20 | Maintains | Overweight | Get Alert |
| 02/03/2025 | BSX | Buy Now | Boston Scientific | $105.00 | 9.52% | Matt O'Brien51% | $95 → $115 | Maintains | Overweight | Get Alert |
| 01/27/2025 | GKOS | Buy Now | Glaukos | $87.61 | 105.46% | Matt O'Brien51% | $140 → $180 | Reiterates | Overweight → Overweight | Get Alert |
| 12/11/2024 | TMDX | Buy Now | TransMedics Gr | $90.50 | -0.55% | Matt O'Brien51% | $110 → $90 | Maintains | Overweight | Get Alert |
| 11/20/2024 | TMDX | Buy Now | TransMedics Gr | $90.50 | 21.55% | Matt O'Brien51% | $180 → $110 | Maintains | Overweight | Get Alert |
| 11/20/2024 | PEN | Buy Now | Penumbra | $296.00 | -15.54% | Matt O'Brien51% | $235 → $250 | Maintains | Overweight | Get Alert |
| 11/08/2024 | RCEL | Buy Now | AVITA Medical | $9.24 | 29.87% | Matt O'Brien51% | $9 → $12 | Reiterates | Neutral → Neutral | Get Alert |
| 11/08/2024 | SGHT | Buy Now | Sight Sciences | $3.05 | 80.33% | Matt O'Brien51% | $6 → $5.5 | Reiterates | Neutral → Neutral | Get Alert |
| 11/08/2024 | TELA | Buy Now | TELA Bio | $1.00 | 399.7% | Matt O'Brien51% | $8 → $5 | Maintains | Overweight | Get Alert |
| 11/06/2024 | GMED | Buy Now | Globus Medical | $71.91 | 39.06% | Matt O'Brien51% | $80 → $100 | Maintains | Overweight | Get Alert |
| 10/31/2024 | PEN | Buy Now | Penumbra | $296.00 | -20.61% | Matt O'Brien51% | $225 → $235 | Maintains | Overweight | Get Alert |
| 10/30/2024 | CVRX | Buy Now | CVRx | $7.95 | 101.26% | Matt O'Brien51% | $13 → $16 | Reiterates | Overweight → Overweight | Get Alert |
| 10/30/2024 | SYK | Buy Now | Stryker | $378.22 | 11.05% | Matt O'Brien51% | $380 → $420 | Reiterates | Overweight → Overweight | Get Alert |
| 10/29/2024 | TMDX | Buy Now | TransMedics Gr | $90.50 | 98.9% | Matt O'Brien51% | $180 → $180 | Reiterates | Overweight → Overweight | Get Alert |
| 10/25/2024 | ITGR | Buy Now | Integer Holdings | $125.66 | 11.41% | Matt O'Brien51% | $125 → $140 | Reiterates | Overweight → Overweight | Get Alert |
| 10/18/2024 | PEN | Buy Now | Penumbra | $296.00 | -23.99% | Matt O'Brien51% | $200 → $225 | Reiterates | Overweight → Overweight | Get Alert |
| 10/08/2024 | PRCT | Buy Now | PROCEPT BioRobotics | $54.47 | 37.69% | Matt O'Brien51% | $75 → $75 | Reiterates | Overweight → Overweight | Get Alert |
| 10/07/2024 | TMDX | Buy Now | TransMedics Gr | $90.50 | 98.9% | Matt O'Brien51% | $180 → $180 | Maintains | Overweight | Get Alert |
| 09/17/2024 | PODD | Buy Now | Insulet | $257.01 | 10.89% | Matt O'Brien51% | $230 → $285 | Maintains | Overweight | Get Alert |
| 09/10/2024 | SYK | Buy Now | Stryker | $378.22 | 0.47% | Matt O'Brien51% | $380 → $380 | Maintains | Overweight | Get Alert |
| 08/26/2024 | DXCM | Buy Now | DexCom | $81.28 | 10.73% | Matt O'Brien51% | $90 → $90 | Reiterates | Overweight → Overweight | Get Alert |
| 08/21/2024 | MDT | Buy Now | Medtronic | $84.85 | 6.07% | Matt O'Brien51% | $85 → $90 | Maintains | Neutral | Get Alert |
| 08/13/2024 | TELA | Buy Now | TELA Bio | $1.00 | 699.52% | Matt O'Brien51% | $10 → $8 | Maintains | Overweight | Get Alert |
| 08/09/2024 | CUTR | Buy Now | Cutera | — | — | Matt O'Brien51% | $3 → $1 | Reiterates | Neutral → Neutral | Get Alert |
| 08/09/2024 | FNA | Buy Now | Paragon 28 | $13.11 | -8.47% | Matt O'Brien51% | $15 → $12 | Reiterates | Overweight → Overweight | Get Alert |
| 08/02/2024 | TNDM | Buy Now | Tandem Diabetes Care | $21.30 | 158.22% | Matt O'Brien51% | $50 → $55 | Reiterates | Overweight → Overweight | Get Alert |
| 08/01/2024 | TMDX | Buy Now | TransMedics Gr | $90.50 | 98.9% | Matt O'Brien51% | $170 → $180 | Maintains | Overweight | Get Alert |
| 08/01/2024 | ATEC | Buy Now | Alphatec Holdings | $12.00 | — | Matt O'Brien51% | $17 → $12 | Maintains | Overweight | Get Alert |
| 08/01/2024 | GKOS | Buy Now | Glaukos | $87.61 | 59.8% | Matt O'Brien51% | $110 → $140 | Maintains | Overweight | Get Alert |
| 08/01/2024 | CNMD | Buy Now | Conmed | $57.68 | 38.7% | Matt O'Brien51% | $95 → $80 | Maintains | Overweight | Get Alert |
| 07/31/2024 | ATRC | Buy Now | AtriCure | $30.02 | 33.24% | Matt O'Brien51% | $65 → $40 | Maintains | Overweight | Get Alert |
| 07/31/2024 | PEN | Buy Now | Penumbra | $296.00 | -32.43% | Matt O'Brien51% | $260 → $200 | Maintains | Overweight | Get Alert |
| 07/30/2024 | CVRX | Buy Now | CVRx | $7.95 | 63.52% | Matt O'Brien51% | $15 → $13 | Maintains | Overweight | Get Alert |
| 07/26/2024 | DXCM | Buy Now | DexCom | $81.28 | 10.73% | Matt O'Brien51% | $150 → $90 | Maintains | Overweight | Get Alert |
| 07/15/2024 | TMDX | Buy Now | TransMedics Gr | $90.50 | 87.85% | Matt O'Brien51% | $120 → $170 | Maintains | Overweight | Get Alert |
| 07/01/2024 | TFX | Buy Now | Teleflex | $126.41 | 93.81% | Matt O'Brien51% | $205 → $245 | Upgrade | Neutral → Overweight | Get Alert |
| 06/21/2024 | CUTR | Buy Now | Cutera | — | — | Matt O'Brien51% | $3 → $3 | Maintains | Neutral | Get Alert |
| 06/21/2024 | TMDX | Buy Now | TransMedics Gr | $90.50 | 32.6% | Matt O'Brien51% | $120 → $120 | Maintains | Overweight | Get Alert |
| 05/20/2024 | GMED | Buy Now | Globus Medical | $71.91 | 11.25% | Matt O'Brien51% | $60 → $80 | Upgrade | Neutral → Overweight | Get Alert |
| 05/14/2024 | RCEL | Buy Now | AVITA Medical | $9.24 | -2.6% | Matt O'Brien51% | $21 → $9 | Downgrade | Overweight → Neutral | Get Alert |
| 05/10/2024 | TELA | Buy Now | TELA Bio | $1.00 | 899.4% | Matt O'Brien51% | $12 → $10 | Reiterates | Overweight → Overweight | Get Alert |
| 05/09/2024 | FNA | Buy Now | Paragon 28 | $13.11 | 14.42% | Matt O'Brien51% | $18 → $15 | Reiterates | Overweight → Overweight | Get Alert |
| 05/08/2024 | PEN | Buy Now | Penumbra | $296.00 | -12.16% | Matt O'Brien51% | $290 → $260 | Maintains | Overweight | Get Alert |
| 05/08/2024 | GMED | Buy Now | Globus Medical | $71.91 | -16.56% | Matt O'Brien51% | $55 → $60 | Maintains | Neutral | Get Alert |
| 05/08/2024 | STAA | Buy Now | Staar Surgical | $19.03 | 110.19% | Matt O'Brien51% | $33 → $40 | Maintains | Neutral | Get Alert |
| 05/06/2024 | PRCT | Buy Now | PROCEPT BioRobotics | $54.47 | 37.69% | Matt O'Brien51% | $67 → $75 | Maintains | Overweight | Get Alert |
| 05/03/2024 | SGHT | Buy Now | Sight Sciences | $3.05 | 96.72% | Matt O'Brien51% | $5 → $6 | Reiterates | Neutral → Neutral | Get Alert |
| 05/03/2024 | TNDM | Buy Now | Tandem Diabetes Care | $21.30 | 134.74% | Matt O'Brien51% | $35 → $50 | Reiterates | Overweight → Overweight | Get Alert |
| 05/01/2024 | TMDX | Buy Now | TransMedics Gr | $90.50 | 32.6% | Matt O'Brien51% | $95 → $120 | Reiterates | Overweight → Overweight | Get Alert |
| 05/01/2024 | CVRX | Buy Now | CVRx | $7.95 | 88.68% | Matt O'Brien51% | $33 → $15 | Maintains | Overweight | Get Alert |
| 05/01/2024 | SYK | Buy Now | Stryker | $378.22 | 0.47% | Matt O'Brien51% | $375 → $380 | Maintains | Overweight | Get Alert |
| 04/25/2024 | CNMD | Buy Now | Conmed | $57.68 | 64.7% | Matt O'Brien51% | $100 → $95 | Maintains | Overweight | Get Alert |
| 04/03/2024 | PEN | Buy Now | Penumbra | $296.00 | -2.03% | Matt O'Brien51% | $290 → $290 | Reiterates | Overweight → Overweight | Get Alert |
| 03/28/2024 | TMDX | Buy Now | TransMedics Gr | $90.50 | 4.97% | Matt O'Brien51% | → $95 | Initiates | → Overweight | Get Alert |
| 03/28/2024 | SIBN | Buy Now | SI-BONE | $13.99 | 78.7% | Matt O'Brien51% | → $25 | Initiates | → Overweight | Get Alert |
| 03/27/2024 | FNA | Buy Now | Paragon 28 | $13.11 | 37.3% | Matt O'Brien51% | $18 → $18 | Maintains | Overweight | Get Alert |
| 03/27/2024 | KIDS | Buy Now | OrthoPediatrics | $21.40 | 86.92% | Matt O'Brien51% | → $40 | Reiterates | Overweight → Overweight | Get Alert |
| 03/22/2024 | TELA | Buy Now | TELA Bio | $1.00 | 1099.28% | Matt O'Brien51% | $15 → $12 | Maintains | Overweight | Get Alert |
| 02/27/2024 | STAA | Buy Now | Staar Surgical | $19.03 | 73.41% | Matt O'Brien51% | $40 → $33 | Maintains | Neutral | Get Alert |
| 02/23/2024 | RCEL | Buy Now | AVITA Medical | $9.24 | 127.27% | Matt O'Brien51% | $19 → $21 | Reiterates | Overweight → Overweight | Get Alert |
| 02/23/2024 | PEN | Buy Now | Penumbra | $296.00 | -2.03% | Matt O'Brien51% | $310 → $290 | Reiterates | Overweight → Overweight | Get Alert |
| 02/23/2024 | PODD | Buy Now | Insulet | $257.01 | -10.51% | Matt O'Brien51% | $250 → $230 | Maintains | Overweight | Get Alert |
| 02/01/2024 | CNMD | Buy Now | Conmed | $57.68 | 73.37% | Matt O'Brien51% | $130 → $100 | Maintains | Overweight | Get Alert |
| 01/26/2024 | CVRX | Buy Now | CVRx | $7.95 | 315.09% | Matt O'Brien51% | $21 → $33 | Maintains | Overweight | Get Alert |
| 12/22/2023 | GKOS | Buy Now | Glaukos | $87.61 | 19.85% | Matt O'Brien51% | $90 → $105 | Maintains | Overweight | Get Alert |
| 12/19/2023 | DXCM | Buy Now | DexCom | $81.28 | 84.55% | Matt O'Brien51% | $135 → $150 | Maintains | Overweight | Get Alert |
| 11/10/2023 | HUMA | Buy Now | Humacyte | $1.30 | 130.77% | Matt O'Brien51% | $3.5 → $3 | Maintains | Neutral | Get Alert |
| 11/10/2023 | RCEL | Buy Now | AVITA Medical | $9.24 | 105.63% | Matt O'Brien51% | $23 → $19 | Maintains | Overweight | Get Alert |
| 11/09/2023 | CUTR | Buy Now | Cutera | — | — | Matt O'Brien51% | $18 → $3 | Maintains | Neutral | Get Alert |
| 11/06/2023 | TFX | Buy Now | Teleflex | $126.41 | 77.99% | Matt O'Brien51% | $210 → $225 | Maintains | Neutral | Get Alert |
| 11/03/2023 | PEN | Buy Now | Penumbra | $296.00 | -15.54% | Matt O'Brien51% | $335 → $250 | Maintains | Overweight | Get Alert |
| 11/03/2023 | PODD | Buy Now | Insulet | $257.01 | -2.73% | Matt O'Brien51% | $325 → $250 | Maintains | Overweight | Get Alert |
| 11/02/2023 | TNDM | Buy Now | Tandem Diabetes Care | $21.30 | 17.37% | Matt O'Brien51% | $40 → $25 | Maintains | Overweight | Get Alert |
| 11/02/2023 | STAA | Buy Now | Staar Surgical | $19.03 | 110.19% | Matt O'Brien51% | $45 → $40 | Maintains | Neutral | Get Alert |
| 10/27/2023 | CNMD | Buy Now | Conmed | $57.68 | 125.38% | Matt O'Brien51% | $145 → $130 | Maintains | Overweight | Get Alert |
| 09/19/2023 | PEN | Buy Now | Penumbra | $296.00 | 13.18% | Matt O'Brien51% | → $335 | Reiterates | Overweight → Overweight | Get Alert |
| 09/15/2023 | STAA | Buy Now | Staar Surgical | $19.03 | 136.47% | Matt O'Brien51% | $50 → $45 | Maintains | Neutral | Get Alert |
| 09/12/2023 | SGHT | Buy Now | Sight Sciences | $3.05 | 80.33% | Matt O'Brien51% | $15 → $5.5 | Downgrade | Overweight → Neutral | Get Alert |
| 08/11/2023 | RCEL | Buy Now | AVITA Medical | $9.24 | 148.92% | Matt O'Brien51% | $18.5 → $23 | Maintains | Overweight | Get Alert |
| 08/11/2023 | APYX | Buy Now | Apyx Medical | $0.90 | 400% | Matt O'Brien51% | $4 → $4.5 | Maintains | Overweight | Get Alert |
| 08/11/2023 | PRCT | Buy Now | PROCEPT BioRobotics | $54.47 | -22.89% | Matt O'Brien51% | → $42 | Initiates | → Overweight | Get Alert |
| 08/03/2023 | GKOS | Buy Now | Glaukos | $87.61 | 2.73% | Matt O'Brien51% | $85 → $90 | Maintains | Overweight | Get Alert |
| 08/03/2023 | STAA | Buy Now | Staar Surgical | $19.03 | 162.74% | Matt O'Brien51% | $65 → $50 | Maintains | Neutral | Get Alert |
| 07/31/2023 | GKOS | Buy Now | Glaukos | $87.61 | -2.98% | Matt O'Brien51% | $80 → $85 | Maintains | Overweight | Get Alert |
| 07/28/2023 | DXCM | Buy Now | DexCom | $81.28 | 96.86% | Matt O'Brien51% | $150 → $160 | Maintains | Overweight | Get Alert |
| 07/27/2023 | CUTR | Buy Now | Cutera | — | — | Matt O'Brien51% | $14 → $18 | Upgrade | Underweight → Neutral | Get Alert |
| 07/06/2023 | BSX | Buy Now | Boston Scientific | $105.00 | -40.95% | Matt O'Brien51% | $58 → $62 | Maintains | Overweight | Get Alert |
| 06/07/2023 | GKOS | Buy Now | Glaukos | $87.61 | -8.69% | Matt O'Brien51% | $55 → $80 | Upgrade | Neutral → Overweight | Get Alert |
| 05/24/2023 | PEN | Buy Now | Penumbra | $296.00 | 13.18% | Matt O'Brien51% | $300 → $335 | Maintains | Overweight | Get Alert |
| 05/12/2023 | MIRO | Buy Now | Miromatrix Medical | — | — | Matt O'Brien51% | $6 → $3 | Maintains | Overweight | Get Alert |
| 05/12/2023 | RCEL | Buy Now | AVITA Medical | $9.24 | 100.22% | Matt O'Brien51% | $16 → $18.5 | Maintains | Overweight | Get Alert |
| 05/10/2023 | CUTR | Buy Now | Cutera | — | — | Matt O'Brien51% | → $14 | Reinstates | → Underweight | Get Alert |
| 05/05/2023 | PODD | Buy Now | Insulet | $257.01 | 40.07% | Matt O'Brien51% | $340 → $360 | Maintains | Overweight | Get Alert |
| 05/03/2023 | PEN | Buy Now | Penumbra | $296.00 | 1.35% | Matt O'Brien51% | $285 → $300 | Maintains | Overweight | Get Alert |
| 05/03/2023 | UTRS | Buy Now | Minerva Surgical | $1.53 | -34.64% | Matt O'Brien51% | $100 → $20 | Maintains | Overweight | Get Alert |
| 05/02/2023 | SYK | Buy Now | Stryker | $378.22 | -18.04% | Matt O'Brien51% | $280 → $310 | Maintains | Overweight | Get Alert |
| 04/27/2023 | CNMD | Buy Now | Conmed | $57.68 | 121.91% | Matt O'Brien51% | $118 → $128 | Maintains | Overweight | Get Alert |
| 04/17/2023 | STAA | Buy Now | Staar Surgical | $19.03 | 241.57% | Matt O'Brien51% | → $65 | Initiates | → Neutral | Get Alert |
| 04/03/2023 | MIRO | Buy Now | Miromatrix Medical | — | — | Matt O'Brien51% | $9 → $6 | Maintains | Overweight | Get Alert |
| 03/10/2023 | ZBH | Buy Now | Zimmer Biomet Holdings | $102.38 | — | Matt O'Brien51% | — | Upgrade | Neutral → Overweight | Get Alert |
| 02/24/2023 | OBIO | Buy Now | Orchestra BioMed Hldgs | $2.74 | 447.45% | Matt O'Brien51% | → $15 | Initiates | → Overweight | Get Alert |
| 02/24/2023 | ITGR | Buy Now | Integer Holdings | $125.66 | -32.36% | Matt O'Brien51% | → $85 | Initiates | → Overweight | Get Alert |
| 02/23/2023 | TNDM | Buy Now | Tandem Diabetes Care | $21.30 | 134.74% | Matt O'Brien51% | $70 → $50 | Maintains | Overweight | Get Alert |
| 02/10/2023 | CVRX | Buy Now | CVRx | $7.95 | 151.57% | Matt O'Brien51% | $18.5 → $20 | Maintains | Overweight | Get Alert |
| 02/09/2023 | GMED | Buy Now | Globus Medical | $71.91 | — | Matt O'Brien51% | — | Downgrade | Overweight → Neutral | Get Alert |
| 02/09/2023 | NUVA | Buy Now | NuVasive | — | — | Matt O'Brien51% | — | Downgrade | Overweight → Neutral | Get Alert |
| 02/03/2023 | CNMD | Buy Now | Conmed | $57.68 | 104.58% | Matt O'Brien51% | $108 → $118 | Maintains | Overweight | Get Alert |
| 02/01/2023 | SYK | Buy Now | Stryker | $378.22 | -25.97% | Matt O'Brien51% | $250 → $280 | Maintains | Overweight | Get Alert |
| 01/30/2023 | PEN | Buy Now | Penumbra | $296.00 | -7.09% | Matt O'Brien51% | → $275 | Initiates | → Overweight | Get Alert |
| 11/15/2022 | AZYO | Buy Now | Aziyo Biologics | — | — | Matt O'Brien51% | $9 → $10.5 | Maintains | Overweight | Get Alert |
| 11/15/2022 | MIRO | Buy Now | Miromatrix Medical | — | — | Matt O'Brien51% | $8 → $9 | Maintains | Overweight | Get Alert |
| 11/15/2022 | MOTS | Buy Now | Motus GI Hldgs | — | — | Matt O'Brien51% | $150 → $90 | Maintains | Overweight | Get Alert |
| 11/10/2022 | NUVA | Buy Now | NuVasive | — | — | Matt O'Brien51% | $60 → $50 | Maintains | Overweight | Get Alert |
| 11/10/2022 | TELA | Buy Now | TELA Bio | $1.00 | 1399.1% | Matt O'Brien51% | $20 → $15 | Maintains | Overweight | Get Alert |
| 11/04/2022 | PODD | Buy Now | Insulet | $257.01 | 32.29% | Matt O'Brien51% | $235 → $340 | Upgrade | Neutral → Overweight | Get Alert |
| 11/03/2022 | TNDM | Buy Now | Tandem Diabetes Care | $21.30 | 228.64% | Matt O'Brien51% | $80 → $70 | Maintains | Overweight | Get Alert |
| 11/03/2022 | GKOS | Buy Now | Glaukos | $87.61 | -31.51% | Matt O'Brien51% | $55 → $60 | Maintains | Neutral | Get Alert |
| 11/02/2022 | CVRX | Buy Now | CVRx | $7.95 | 76.1% | Matt O'Brien51% | $10 → $14 | Maintains | Overweight | Get Alert |
| 11/01/2022 | ABMD | Buy Now | Abiomed | — | — | Matt O'Brien51% | $350 → $380 | Downgrade | Overweight → Neutral | Get Alert |
| 10/10/2022 | ABMD | Buy Now | Abiomed | — | — | Matt O'Brien51% | $425 → $350 | Maintains | Overweight | Get Alert |
| 10/07/2022 | DXCM | Buy Now | DexCom | $81.28 | 47.64% | Matt O'Brien51% | $110 → $120 | Maintains | Overweight | Get Alert |
| 09/14/2022 | SYK | Buy Now | Stryker | $378.22 | -31.26% | Matt O'Brien51% | $250 → $260 | Maintains | Overweight | Get Alert |
| 09/09/2022 | BSX | Buy Now | Boston Scientific | $105.00 | -52.38% | Matt O'Brien51% | $47 → $50 | Maintains | Overweight | Get Alert |
| 08/31/2022 | MIRO | Buy Now | Miromatrix Medical | — | — | Matt O'Brien51% | → $8 | Initiates | → Overweight | Get Alert |
| 08/12/2022 | APYX | Buy Now | Apyx Medical | $0.90 | 1233.33% | Matt O'Brien51% | $6 → $12 | Maintains | Overweight | Get Alert |
| 08/12/2022 | SGHT | Buy Now | Sight Sciences | $3.05 | 391.8% | Matt O'Brien51% | $17 → $15 | Maintains | Overweight | Get Alert |
| 08/10/2022 | UTRS | Buy Now | Minerva Surgical | $1.53 | 226.8% | Matt O'Brien51% | $120 → $100 | Maintains | Overweight | Get Alert |
| 08/05/2022 | CUTR | Buy Now | Cutera | — | — | Matt O'Brien51% | $65 → $55 | Maintains | Overweight | Get Alert |
| 08/05/2022 | PODD | Buy Now | Insulet | $257.01 | -8.56% | Matt O'Brien51% | $230 → $235 | Maintains | Neutral | Get Alert |
| 08/05/2022 | GMED | Buy Now | Globus Medical | $71.91 | 4.3% | Matt O'Brien51% | $80 → $75 | Maintains | Overweight | Get Alert |
| 08/04/2022 | NUVA | Buy Now | NuVasive | — | — | Matt O'Brien51% | $80 → $60 | Maintains | Overweight | Get Alert |
| 08/04/2022 | TNDM | Buy Now | Tandem Diabetes Care | $21.30 | 275.59% | Matt O'Brien51% | $120 → $80 | Maintains | Overweight | Get Alert |
| 08/03/2022 | SPNE | Buy Now | SeaSpine Holdings | — | — | Matt O'Brien51% | $21 → $12 | Maintains | Overweight | Get Alert |
| 08/03/2022 | ATRC | Buy Now | AtriCure | $30.02 | 83.21% | Matt O'Brien51% | $90 → $55 | Maintains | Overweight | Get Alert |
| 07/29/2022 | DXCM | Buy Now | DexCom | $81.28 | 35.34% | Matt O'Brien51% | $120 → $110 | Maintains | Overweight | Get Alert |
| 07/28/2022 | CNMD | Buy Now | Conmed | $57.68 | 104.58% | Matt O'Brien51% | $160 → $118 | Maintains | Overweight | Get Alert |
| 07/27/2022 | SYK | Buy Now | Stryker | $378.22 | -33.9% | Matt O'Brien51% | $290 → $250 | Maintains | Overweight | Get Alert |
| 05/27/2022 | MDT | Buy Now | Medtronic | $84.85 | 17.86% | Matt O'Brien51% | $105 → $100 | Maintains | Neutral | Get Alert |
| 05/12/2022 | UTRS | Buy Now | Minerva Surgical | $1.53 | 292.16% | Matt O'Brien51% | $240 → $120 | Maintains | Overweight | Get Alert |
| 05/11/2022 | SGHT | Buy Now | Sight Sciences | $3.05 | 457.38% | Matt O'Brien51% | $23 → $17 | Maintains | Overweight | Get Alert |
| 05/05/2022 | TNDM | Buy Now | Tandem Diabetes Care | $21.30 | 463.38% | Matt O'Brien51% | $170 → $120 | Maintains | Overweight | Get Alert |
| 04/29/2022 | SYK | Buy Now | Stryker | $378.22 | -23.33% | Matt O'Brien51% | $315 → $290 | Maintains | Overweight | Get Alert |
| 04/29/2022 | DXCM | Buy Now | DexCom | $81.28 | 490.57% | Matt O'Brien51% | $181.25 → $120 | Maintains | Overweight | Get Alert |
| 03/09/2022 | UTRS | Buy Now | Minerva Surgical | $1.53 | 684.31% | Matt O'Brien51% | $340 → $240 | Maintains | Overweight | Get Alert |
| 02/16/2022 | MDT | Buy Now | Medtronic | $84.85 | 23.75% | Matt O'Brien51% | $110 → $105 | Maintains | Neutral | Get Alert |
| 01/04/2022 | ZBH | Buy Now | Zimmer Biomet Holdings | $102.38 | 31.86% | Matt O'Brien51% | $185 → $135 | Downgrade | Overweight → Neutral | Get Alert |
| 01/04/2022 | TFX | Buy Now | Teleflex | $126.41 | 157.1% | Matt O'Brien51% | $465 → $325 | Downgrade | Overweight → Neutral | Get Alert |
| 01/04/2022 | GMED | Buy Now | Globus Medical | $71.91 | 22.38% | Matt O'Brien51% | $80 → $88 | Upgrade | Neutral → Overweight | Get Alert |
| 01/04/2022 | MDT | Buy Now | Medtronic | $84.85 | 29.64% | Matt O'Brien51% | $152 → $110 | Downgrade | Overweight → Neutral | Get Alert |
| 01/04/2022 | SYK | Buy Now | Stryker | $378.22 | -16.72% | Matt O'Brien51% | $250 → $315 | Upgrade | Neutral → Overweight | Get Alert |
| 11/16/2021 | UTRS | Buy Now | Minerva Surgical | $1.53 | 1011.11% | Matt O'Brien51% | → $340 | Initiates | → Overweight | Get Alert |
| 11/09/2021 | FNA | Buy Now | Paragon 28 | $13.11 | 128.83% | Matt O'Brien51% | → $30 | Initiates | → Overweight | Get Alert |
| 11/03/2021 | DXCM | Buy Now | DexCom | $81.28 | 822.77% | Matt O'Brien51% | $168.75 → $187.5 | Maintains | Overweight | Get Alert |
| 09/16/2021 | DXCM | Buy Now | DexCom | $81.28 | 699.74% | Matt O'Brien51% | $137.5 → $162.5 | Maintains | Overweight | Get Alert |
| 09/16/2021 | HUMA | Buy Now | Humacyte | $1.30 | 1207.69% | Matt O'Brien51% | → $17 | Initiates | → Overweight | Get Alert |
| 08/09/2021 | SGHT | Buy Now | Sight Sciences | $3.05 | 1342.62% | Matt O'Brien51% | → $44 | Initiates | → Overweight | Get Alert |
| 07/30/2021 | DXCM | Buy Now | DexCom | $81.28 | 576.7% | Matt O'Brien51% | $125 → $137.5 | Maintains | Overweight | Get Alert |
| 07/26/2021 | CVRX | Buy Now | CVRx | $7.95 | 227.04% | Matt O'Brien51% | → $26 | Initiates | → Overweight | Get Alert |
| 05/06/2021 | NUVA | Buy Now | NuVasive | — | — | Matt O'Brien51% | $75 → $80 | Maintains | Overweight | Get Alert |
| 04/29/2021 | CNMD | Buy Now | Conmed | $57.68 | 177.39% | Matt O'Brien51% | $145 → $160 | Maintains | Overweight | Get Alert |
| 03/02/2021 | RCEL | Buy Now | AVITA Medical | $9.24 | 192.21% | Matt O'Brien51% | → $27 | Initiates | → Overweight | Get Alert |
| 02/11/2021 | COO | Buy Now | Cooper Companies | $82.35 | 428.23% | Matt O'Brien51% | $92.5 → $108.75 | Maintains | Overweight | Get Alert |
| 02/02/2021 | SRGA | Buy Now | Surgalign Holdings | — | — | Matt O'Brien51% | → $120 | Initiates | → Overweight | Get Alert |
| 01/29/2021 | ZYXI | Buy Now | Zynex | $2.35 | 749.91% | Matt O'Brien51% | $25.45 → $18.18 | Downgrade | Overweight → Neutral | Get Alert |
| 01/29/2021 | PODD | Buy Now | Insulet | $257.01 | — | Matt O'Brien51% | — | Downgrade | Overweight → Neutral | Get Alert |
| 01/29/2021 | BAX | Buy Now | Baxter Intl | $30.71 | 160.5% | Matt O'Brien51% | $100 → $80 | Downgrade | Overweight → Neutral | Get Alert |
| 01/29/2021 | GKOS | Buy Now | Glaukos | $87.61 | -8.69% | Matt O'Brien51% | $70 → $80 | Downgrade | Overweight → Neutral | Get Alert |
| 11/05/2020 | CUTR | Buy Now | Cutera | — | — | Matt O'Brien51% | $22 → $28 | Maintains | Overweight | Get Alert |
| 09/30/2020 | CUTR | Buy Now | Cutera | — | — | Matt O'Brien51% | $18 → $22 | Maintains | Overweight | Get Alert |
| 08/06/2020 | GMED | Buy Now | Globus Medical | $71.91 | -23.52% | Matt O'Brien51% | $50 → $55 | Maintains | Neutral | Get Alert |
| 07/30/2020 | CNMD | Buy Now | Conmed | $57.68 | 64.7% | Matt O'Brien51% | $90 → $95 | Maintains | Overweight | Get Alert |
| 07/20/2020 | ZYXI | Buy Now | Zynex | $2.35 | 1174.86% | Matt O'Brien51% | → $27.27 | Initiates | → Overweight | Get Alert |
| 07/06/2020 | GMED | Buy Now | Globus Medical | $71.91 | -30.47% | Matt O'Brien51% | $60 → $50 | Downgrade | Overweight → Neutral | Get Alert |
| 06/24/2020 | KRMD | Buy Now | KORU Medical Systems | $2.77 | 333.21% | Matt O'Brien51% | → $12 | Initiates | → Overweight | Get Alert |
| 05/22/2020 | MDT | Buy Now | Medtronic | $84.85 | 41.43% | Matt O'Brien51% | $135 → $120 | Maintains | Overweight | Get Alert |
| 04/22/2020 | CUTR | Buy Now | Cutera | — | — | Matt O'Brien51% | → $18 | Initiates | → Overweight | Get Alert |
| 01/22/2020 | MDT | Buy Now | Medtronic | $84.85 | 59.1% | Matt O'Brien51% | $125 → $135 | Maintains | Overweight | Get Alert |
| 11/07/2019 | GMED | Buy Now | Globus Medical | $71.91 | -9.61% | Matt O'Brien51% | $62 → $65 | Maintains | Overweight | Get Alert |
| 08/22/2019 | CNMD | Buy Now | Conmed | $57.68 | 90.71% | Matt O'Brien51% | $88 → $110 | Upgrade | Neutral → Overweight | Get Alert |
| 07/26/2019 | SYK | Buy Now | Stryker | $378.22 | -36.54% | Matt O'Brien51% | $205 → $240 | Maintains | Overweight | Get Alert |
| 02/09/2016 | GKOS | Buy Now | Glaukos | $87.61 | — | Matt O'Brien51% | — | Initiates | → Overweight | Get Alert |
| 11/30/2015 | TFX | Buy Now | Teleflex | $126.41 | 21.03% | Matt O'Brien51% | → $153 | Initiates | → Overweight | Get Alert |
| 05/08/2015 | CUTR | Buy Now | Cutera | — | — | Matt O'Brien51% | $14 → $17 | Upgrade | Neutral → Overweight | Get Alert |
| 04/23/2015 | CNMD | Buy Now | Conmed | $57.68 | -11.58% | Matt O'Brien51% | $47 → $51 | Maintains | Neutral | Get Alert |
| 01/07/2015 | GMED | Buy Now | Globus Medical | $71.91 | -61.06% | Matt O'Brien51% | → $28 | Initiates | → Overweight | Get Alert |
| 11/20/2013 | MDT | Buy Now | Medtronic | $84.85 | -19.86% | Matt O'Brien51% | $58 → $68 | Maintains | Overweight | Get Alert |
| 08/06/2013 | CUTR | Buy Now | Cutera | — | — | Matt O'Brien51% | $12 → $11 | Downgrade | Overweight → Neutral | Get Alert |
| 02/27/2013 | NUVA | Buy Now | NuVasive | — | — | Matt O'Brien51% | $23 → $24 | Maintains | Overweight | Get Alert |
| 02/19/2013 | MDT | Buy Now | Medtronic | $84.85 | -41.07% | Matt O'Brien51% | $48 → $50 | Maintains | Overweight | Get Alert |
| 10/31/2012 | CNMD | Buy Now | Conmed | $57.68 | -42.79% | Matt O'Brien51% | $31 → $33 | Maintains | Neutral | Get Alert |
| 10/01/2012 | GMED | Buy Now | Globus Medical | $71.91 | -70.8% | Matt O'Brien51% | $18 → $21 | Maintains | Overweight | Get Alert |
| 08/22/2012 | MDT | Buy Now | Medtronic | $84.85 | -46.97% | Matt O'Brien51% | $44 → $45 | Maintains | Overweight | Get Alert |
| 08/02/2012 | SYK | Buy Now | Stryker | $378.22 | -83.87% | Matt O'Brien51% | $65 → $61 | Downgrade | Overweight → Neutral | Get Alert |
| 07/03/2012 | CUTR | Buy Now | Cutera | — | — | Matt O'Brien51% | $12 → $10 | Maintains | Overweight | Get Alert |
| 04/18/2012 | SYK | Buy Now | Stryker | $378.22 | -82.81% | Matt O'Brien51% | $67 → $65 | Maintains | Overweight | Get Alert |
